Literature DB >> 12189484

DNA hypermethylation: when tumour suppressor genes go silent.

George A Garinis1, George P Patrinos, Nick E Spanakis, Panayiotis G Menounos.   

Abstract

The phenotype of the cancerous cell may arise either from genetic alterations that disrupt gene function through sequence modifications (mutations) or epigenetic events that may alter the heritable state of gene expression (i.e. without changing the actual sequence of the genome). Whereas mutations in certain tumour suppressor genes are most often thought of in association with their inactivation during cancer initiation or progression, epigenetic alterations such as DNA methylation appear to be tightly linked to the sequential non-reversible events of normal tissue differentiation and organogenesis. This highlights a link between tissue differentiation and tumourigenesis with respect to the stable nature of certain epigenetic changes. In the case of tumourigenesis, both genetic and epigenetic mechanisms of altered gene expression often go hand in hand; not surprisingly, biallelic inactivation of a given tumour suppressor gene may occur via a combination of mutational and epigenetic events and is entirely consistent with the Knudson two-hit hypothesis of tumourigenesis. This review summarizes recent developments within the field of DNA methylation, highlighting its association with the transcriptional silencing of tumour suppressor genes in a variety of human cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189484     DOI: 10.1007/s00439-002-0783-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.

Authors:  Xue-Xi Yang; Jing-Zhe Sun; Fen-Xia Li; Ying-Song Wu; Hong-Yan Du; Wei Zhu; Xiang-Hong Li; Ming Li
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

2.  Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability.

Authors:  Dian-Chun Fang; Rong-Quan Wang; Shi-Ming Yang; Jian-Ming Yang; Hai-Feng Liu; Gui-Yong Peng; Tian-Li Xiao; Yuan-Hui Luo
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Authors:  Jing-Zhe Sun; Xue-Xi Yang; Xiang-Hong Li; Wei-Wen Xu; Ying Wang; Wei Zhu; Ming Li
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

4.  Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.

Authors:  Ying Zhang; Naheed Fatima; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 5.  Methylation in esophageal carcinogenesis.

Authors:  Da-Long Wu; Feng-Ying Sui; Xiao-Ming Jiang; Xiao-Hong Jiang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

6.  Epigenetic perturbations in the pathogenesis of mustard toxicity; hypothesis and preliminary results.

Authors:  Ahmet Korkmaz; Hakan Yaren; Z Ilker Kunak; Bulent Uysal; Bulent Kurt; Turgut Topal; Levent Kenar; Ergun Ucar; Sukru Oter
Journal:  Interdiscip Toxicol       Date:  2008-12

7.  Glucose-6-phosphate dehydrogenase deficiency does not result from mutations in the promoter region of the G6PD gene.

Authors:  Panayiotis G Menounos; George A Garinis; George P Patrinos
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

8.  Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study.

Authors:  Lihui Wang; Pan Zhang; Xiannan Meng; Xiang Chen; Zou Xiang; Xiaoqian Lin; Ye Liu; Weidong Gan; Xiaodong Han; Dongmei Li
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

9.  The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines.

Authors:  Hang Joo Cho; Sin Young Kim; Kee Hwan Kim; Won Kyung Kang; Ji Il Kim; Seong Tack Oh; Jeong Soo Kim; Chang Hyeok An
Journal:  World J Surg Oncol       Date:  2009-05-21       Impact factor: 2.754

10.  Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.

Authors:  Marc A Bollet; Alexia Savignoni; Leanne De Koning; Carine Tran-Perennou; Catherine Barbaroux; Armelle Degeorges; Brigitte Sigal-Zafrani; Geneviève Almouzni; Paul Cottu; Rémy Salmon; Nicolas Servant; Alain Fourquet; Patricia de Cremoux
Journal:  Breast Cancer Res       Date:  2009-07-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.